Article Text

S3 Reduced BMPR2 expression potentiates a pulmonary artery smooth muscle cell specific IL-1ß response
  1. J Pickworth1,
  2. S Shay2,
  3. S Gladson2,
  4. J Iremonger1,
  5. AMK Rothman1,
  6. S Francis1,
  7. J West2,
  8. A Lawrie1
  1. 1University of Sheffield, Sheffield, UK
  2. 2Vanderbilt Instiute, Nashville, USA


Introduction and objectives Bone morphogenetic protein receptor type 2 (BMPR2) mutations are found in heritable and idiopathic pulmonary arterial hypertension however penetrance is incomplete implying necessity for a ‘second hit’. IL-1ß and IL-6 are increased in PAH patients and animal models and are thought to have a role in disease. We aimed to determine pulmonary specific interplay between BMPR2 and IL-1ß signalling through assessing IL-1ß responsiveness of pulmonary artery and aortic smooth muscle cells (Ao/PA SMC) and determine the effects of reduced BMPR2.

Methods Microarray analysis of PASMC and AoSMC mRNA was performed using microarray on mRNA isolated from cells cultured in SMGM-2 (Lonza) +/- functional BMPR2 (by use of siRNA) and stimulation with 10 ng/ml IL-1ß for 6 h. Subsequent bioinformatics was performed using R. Findings were validated using quantitative PCR and western blotting. Furthermore R899X+/- BMPR2 transgenic mice were fed western diet for six weeks and injected daily with IL-1ß then assessed for inflammatory activation and PAH phenotype (catheter/echo). mRNA and protein changes were measured by TaqMan PCR, western blotting and serum ELISA. Immuno-staining of paraffin embedded lung sections assessed pulmonary vascular remodelling.

Results Array data shows reduced inflammatory activation in response to IL-1ß in PASMC compared with AoSMCs, analysis of cells lacking functional BMPR2 identified an exaggerated inflammatory response to IL-1ß in PASMC lacking BMPR2 (siRNA). Significant up-regulation of IL-6, IL-1α and adhesion molecules (>2-fold) shown by array analysis was validated by qPCR. In the absence of BMPR2 a 1.5 fold increase in proliferation was observed in response to IL-1ß compared to PASMC with functional BMPR2. Mice treated with IL-1ß show higher white blood cell counts (1.7-fold), and protein levels of OPG and IL-6 (serum) matching in vitro data.

Conclusion IL-1ß induces a pulmonary specific transcriptome altered by suppression of BMPR2 signalling indicating cross-talk between the pathways. In the presence of BMPR2, PASMCs show limited response to IL-1ß however reducing BMPR2 exacerbated this response increasing the likelihood of a PAH phenotype in PASMCs. This highlights a mechanism that increased IL-1ß may provide “second hit” to reduced BMPR2 to stimulate development of PAH.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.